Prostate cancer post-prostatectomy radiotherapy: CT vs MRI for vesico-urethral anastomosis target delineation

Publication date: Available online 19 September 2017
Source:Radiotherapy and Oncology
Author(s): Daryl Lim Joon, Adeline Lim, Michal Schneider, Chee-Yan Hiew, Nathan Lawrentschuk, Shomik Sengupta, Farshad Foroudi, Trish Jenkins, David Angus, Morikatsu Wada, Michael Chao, Vincent Khoo
BackgroundVesico-urethral anastomosis (VUA) is critical to the clinical target volume (CTV) in post-prostatectomy radiotherapy (PPRT), as it is the commonest site of recurrence. Typically, this is performed on a CT alone but guidelines recommend MRI.ObjectiveTo evaluate the VUA spatial differences between CT (ctVUA) and MRI (mrVUA) and analyse its impact on the CT defined CTV (ctCTV) as recommended by published guidelines.Materials and methodsWe identified 34 patients with a co-registered simulation CT and T2 weighted MRI. The VUA was located on CT and MRI whilst blinded to the opposing scan. The differences were analysed using Wilcoxon's Signed Rank Test. The mrVUA coverage was investigated using three ctCTV margins of 5mm, 8mm and 12mm.ResultsMedian age was 63years with 59% having pT3a disease and median Gleason score of 7. The mrVUA was coincident with the ctVUA in 12% and inferior in 88%. Median difference was 5mm (0–10mm) (P<0.0001). Only a ctCTV margin of 12mm would have encompassed all mrVUAs. A ctCTV margin of 8mm and 5mm resulted in 12% and 38% cases where the VUA was excluded from the ctCTV.ConclusionsMRI is important for the accurate delineation of VUA for PPRT.



http://ift.tt/2jIGLhy